Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -30.47%44.94K | -17.52%51.89K | -44.60%44.06K | -68.25%267.39K | -53.68%60.32K | -63.29%64.64K | -63.77%62.91K | -78.05%79.53K | 15.83%842.26K | -45.03%130.22K |
| Selling and administrative expenses | -85.65%2.7K | -4.72%10.16K | -70.75%1.7K | -63.57%61.04K | 10.41%25.74K | 68.70%18.82K | 62.85%10.66K | -95.40%5.82K | -68.57%167.57K | -87.60%23.31K |
| -Selling and marketing expense | ---- | ---- | ---- | -23.38%5.91K | ---- | ---- | ---- | ---- | --7.71K | ---- |
| -General and administrative expense | -85.65%2.7K | -4.72%10.16K | -70.75%1.7K | -65.51%55.13K | 27.12%19.83K | 68.70%18.82K | 62.85%10.66K | -95.40%5.82K | -70.02%159.85K | -91.71%15.6K |
| Other operating expenses | -7.81%42.24K | -20.13%41.73K | -42.54%42.35K | -69.42%206.35K | -67.65%34.59K | -72.21%45.82K | -68.73%52.24K | -68.74%73.71K | 247.78%674.69K | 119.00%106.91K |
| Operating profit | 30.47%-44.94K | 17.52%-51.89K | 44.60%-44.06K | 68.25%-267.39K | 53.68%-60.32K | 63.29%-64.64K | 63.77%-62.91K | 78.05%-79.53K | -15.83%-842.26K | 45.03%-130.22K |
| Net non-operating interest income (expenses) | 0.00%-1.88K | 0.00%-1.88K | 0.00%-1.88K | 0.00%-7.5K | 0.00%-1.88K | 0.00%-1.88K | 0.00%-1.88K | 0.00%-1.88K | 89.72%-7.5K | 66.70%-1.88K |
| Non-operating interest expense | 0.00%1.88K | 0.00%1.88K | 0.00%1.88K | 0.00%7.5K | 0.00%1.88K | 0.00%1.88K | 0.00%1.88K | 0.00%1.88K | -89.72%7.5K | -66.70%1.88K |
| Other net income (expenses) | 13.09K | 0 | ||||||||
| Special income (charges) | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | --13.09K | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.09K | --0 |
| Income before tax | 29.61%-46.81K | 17.01%-53.76K | 43.57%-45.93K | 67.14%-274.89K | 52.91%-62.2K | 62.62%-66.51K | 60.11%-64.78K | 77.65%-81.4K | -4.57%-836.67K | 45.53%-132.1K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 29.61%-46.81K | 17.01%-53.76K | 43.57%-45.93K | 67.14%-274.89K | 52.91%-62.2K | 62.62%-66.51K | 60.11%-64.78K | 77.65%-81.4K | -4.57%-836.67K | 45.53%-132.1K |
| Net income continuous operations | 29.61%-46.81K | 17.01%-53.76K | 43.57%-45.93K | 67.14%-274.89K | 52.91%-62.2K | 62.62%-66.51K | 60.11%-64.78K | 77.65%-81.4K | -4.57%-836.67K | 45.53%-132.1K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 29.61%-46.81K | 17.01%-53.76K | 43.57%-45.93K | 67.14%-274.89K | 52.91%-62.2K | 62.62%-66.51K | 60.11%-64.78K | 77.65%-81.4K | -4.57%-836.67K | 45.53%-132.1K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 29.61%-46.81K | 17.01%-53.76K | 43.57%-45.93K | 67.14%-274.89K | 52.91%-62.2K | 62.62%-66.51K | 60.11%-64.78K | 77.65%-81.4K | -4.57%-836.67K | 45.53%-132.1K |
| Diluted earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-0.02 | 0.00%-0.01 |
| Basic earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-0.02 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.